Psoriasis: Epidemiology, clinical features, and quality of life

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 2, 2005, Pages

  Langley, R G B ^a   Krueger, G G ^b   Griffiths, C E M ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ETHNIC GROUP; HEREDITY; HUMAN; IMMUNE RESPONSE; INFECTION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENT DISEASE;

HEALTH STATUS INDICATORS; HUMANS; PSORIASIS; QUALITY OF LIFE;

EID: 14244267601     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.033217     Document Type: Conference Paper

References (54)

1. Lomholt G. Prevalence of skin disease in a population: A census study From the Faroe islands. Dan Med Bull 1964;11:1-7.
2. Green AC. Australian Aborigines and psoriasis. Australas J Dermatol 1984;25:18-24.
3. Convit J. Investigation of the incidence of psoriasis amongst Latin-American Indians. In: Proceedings of 13th Congress on Dermatology. Amsterdam: Excerpta Medica, 1962:196.
4. Burch PR, Rowell NR. Mode of inheritance in psoriasis. Arch Dermatol 1981;117:251-2.
5. Smith AE, Kassab JY, Rowland Payne, CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993;186:181-6.
6. Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA. Psoriasis of early and late onset: a clinical and epidemiologic study From Spain. J Am Acad Dermatol 2002;46:867-73.
7. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-6.
8. Farber EM, Nall LM. The natural history of psoriasis in 5600 patients. Dermatologica 1974;148:1-18.
9. Yashuda T, Ishikawa E, Mori S. Psoriasis in lfie Japanese. In: Farbert EM, Cox AJ, eds. Psoriasis. Proceedings of the 1st International Symposium. Stanford, CA: Stanford University Press, 1971:25-34.
10. Trembalh RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997;6:813-20.
11. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997;6:1349-56.
12. Capon F, Semprini S, Dallapiccola B, Novelli G. Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am J Hum Genet 1999;65:1798-800.
13. Enlund F, Samuelsson L, Enerback C, Inerot A, Wahlstrom J, Yhr M, et al. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q. Hum Hered 1999;49:2-8.
14. Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, et al. Identification or a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001;38:7-13.
15. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000;66:1833-44, Erratum in: Am J Hum Genet 2002;70:1074.
16. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000;66:1833-44, Erratum in: Am J Hum Genet 2002;70:1074.
17. Capon F, Novelli G, Semprini S, Clementi M, Nudo M, Vultaggio P, et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999;112:32-5.
18. Enlund F, Samuelsson L, Enerback C, Inerot A, Wahlstrom J, Yhr M, et al. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet 1999;7:783-90.
19. Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisher E, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet 1996;14:231-3.
20. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-5.
21. Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, Nurnberg G, et al. Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet 2000;67:1020-4.
22. Martin BA, Chalmers RJ, Telfer NR. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 1996;132:717-18.
23. Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaelsson G, Evans J, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003;120:627-32.
24. O'Doherty CJ, MacIntyre C. Palmoplantar pustulosis and smoking. BMJ (Clin Res Ed) 1985;28:861-4.
25. Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gattlieb AB, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000;43:281-5.
26. Finlay AY, Kelly SE. Psoriasis - An index of disability. Clin Exp Dermatol 1987;12:8-11.
27. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
28. Ginsburg IH, Link BG. Feeling of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989;20:53-63.
29. Gupta MA, Schork NJ, Gupta AK. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-90.
30. Savin JA. Patients' beliefs about psoriasis. Trans St Johns Hosp Dermatol Soc 1970;56:139-42.
31. Richards HL, Fortune DG, Griffiths CE, Maine G. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001;50:11-15.
32. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Assessing illness related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997;42:467-75.
33. Kirby B, Fortune DG, Bhushan M, Chalmers RJ, Griffiths CE. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 2000;142:728-32.
34. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-6.
35. Finlay AY, Kelly SE. Psoriasis-index of disability. Clin Exp Dermatol 1987;12:8-11.
36. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003;139:752-6.
37. Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002: 146, 458-65.
38. Seville RH. Psoriasis and stress. Br J Dermatol 1977;97:297-302.
39. Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39:196-20.
40. Jorgensen C, Bressot N, Bologna C, Sony J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol 1995;22:1829-33.
41. de Korte J, Members FM, Sprangers MA, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002;139:1221-7.
42. de Korte J, Sprangers MA, Members FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004;9:140-7.
43. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004;122:602-7.
44. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). 3 Investig Dermatol Symp Proc 2004;9:169-80.
45. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
46. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9.
47. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, et al. Devlopment of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Brit J Dermatol 2003;149:323.
48. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc 2004;9:160-8.
49. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-72.
50. Pollis AG, Mouzas IA, Vlachonikolis IG. The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis 2004;10:261-9.
51. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-96.
52. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-6.
53. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis, Rheum 1995;38:727-35.
54. Paulus HE, Bulpitt KJ, Ramos B, Park G, Wong WK; Western Consortium of Practicing Rheumatologists. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis. Arthritis Rheum 2000;43:2743-50.